台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    96.4
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    33
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-富邦-三重 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-三重 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/10/1700.001.196.8396.80-1.1137-0.76%
2024/09/2300.00196.5096.40-1138-0.72%
2024/09/060100.0000.0099.5001370.00%
2024/08/1600.000.1104.50105.00-0.1118-0.08%
2024/08/120.1102.5000.00102.500.1990.10%
2024/08/05098.8000.0098.800890.04%
2024/07/260.1101.0000.00101.000.1890.11%
2024/06/2100.001101.00100.50-1140-0.71%
2024/06/170.1101.0000.00101.000.11460.07%
2024/06/130100.5000.00100.5001520.01%
2024/06/121100.5000.00101.0011550.64%
2024/06/110.1103.0000.00101.500.11560.06%
2024/05/2700.000.3102.50102.50-0.3158-0.19%
2024/05/172106.2500.00105.5021521.31%
2024/05/1400.006102.00102.00-6144-4.15%
2024/05/081118.0000.00118.0011190.84%
2024/04/2900.000118.00117.500116-0.02%
2024/04/2200.001116.00116.00-1114-0.88%
2024/04/160114.0000.00114.0001110.01%
2024/04/1500.000116.50117.0001070.00%
2024/04/091124.0000.00124.001771.30%
2024/04/080123.6200.00123.500730.04%
2024/04/030.3123.501123.00123.50-0.771-0.98%
2024/04/011123.0000.00123.001691.44%
2024/03/250123.501123.00124.00-162-1.59%
2024/03/2200.006122.50122.50-660-9.96%
2024/03/191121.0000.00123.001551.81%
2024/03/158121.001120.50121.5074714.86%
2023/08/100113.0000.00112.500300.06%
2023/08/040113.5000.00111.500300.03%
2022/11/0700.002100.50102.50-219-10.49%
2022/10/3100.001100.5099.20-117-5.66%
2022/05/3100.001100.50101.00-144-2.25%
2022/05/18198.0000.0097.901432.30%
2022/04/111133.5000.00134.501224.37%
2022/04/061135.0000.00134.501224.52%
2022/03/241129.5000.00129.501195.11%
2021/10/2100.000128.50127.50037-0.05%
2021/10/2000.000129.50128.00038-0.08%
2021/08/2700.001145.50148.00-135-2.79%
2021/06/1600.001155.00154.50-146-2.14%
2021/04/231146.0000.00146.001382.63%
2021/04/131148.5000.00149.001372.67%
2021/03/2200.001138.00140.50-125-3.87%
2021/03/1900.001136.00136.00-125-3.94%
2021/02/2500.000.1126.00127.00-0.126-0.52%
2020/12/0800.001128.50127.00-132-3.04%
2020/12/031126.5000.00127.001323.09%
2020/05/281109.0000.00108.501531.87%
2020/05/2000.001108.50109.00-152-1.92%
2020/05/151110.0000.00108.001501.98%
2020/03/12398.1000.0098.103309.98%
2020/03/10299.9500.00100.002287.08%
2020/03/021100.0000.00100.501263.73%
2020/02/2400.001101.00101.00-126-3.84%
2019/12/3100.001102.00102.00-120-4.81%
2019/10/231102.0000.00102.001234.30%
2019/08/301101.5000.00101.501412.43%
2019/03/2200.001111.00111.00-130-3.23%
2019/02/271110.0000.00109.001244.04%
2018/11/122104.5000.00104.002296.79%
2018/05/2500.001125.50123.00-1124-0.80%
2018/05/101128.0000.00128.5011270.79%
2018/05/0300.001129.50129.00-1116-0.86%
2018/04/2300.001124.50124.00-1149-0.67%
2018/04/171122.0000.00122.0011630.61%
2018/04/021129.501132.50129.5001620.00%
2018/03/2100.001130.00128.50-1183-0.54%
2018/03/201127.0000.00127.5011780.56%
2018/03/191127.5000.00127.5011760.57%
2018/01/3000.001119.00120.00-1162-0.61%
2018/01/2900.001122.00123.00-1162-0.62%
2018/01/171120.0000.00121.5011290.77%
2018/01/161118.0000.00116.0011180.84%
2018/01/0500.001112.00112.00-199-1.00%
2018/01/0400.002112.50112.00-298-2.04%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音